Archives of Pharmacal Research最新文献

筛选
英文 中文
Targeting vascular endothelial growth receptor-2 (VEGFR-2): structural biology, functional insights, and therapeutic resistance 靶向血管内皮生长受体-2 (VEGFR-2):结构生物学、功能见解和治疗耐药性
IF 6.9 3区 医学
Archives of Pharmacal Research Pub Date : 2025-05-08 DOI: 10.1007/s12272-025-01545-1
Fahad Hassan Shah, Yoon Seok Nam, Jun Young Bang, In Seo Hwang, Dae Hong Kim, Minkyoung Ki, Heon-Woo Lee
{"title":"Targeting vascular endothelial growth receptor-2 (VEGFR-2): structural biology, functional insights, and therapeutic resistance","authors":"Fahad Hassan Shah,&nbsp;Yoon Seok Nam,&nbsp;Jun Young Bang,&nbsp;In Seo Hwang,&nbsp;Dae Hong Kim,&nbsp;Minkyoung Ki,&nbsp;Heon-Woo Lee","doi":"10.1007/s12272-025-01545-1","DOIUrl":"10.1007/s12272-025-01545-1","url":null,"abstract":"<div><p>Angiogenesis, the process of new blood vessel formation, is a fundamental physiological process implicated in several pathological disorders. The vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs) are crucial for angiogenesis and vasculogenesis. Among them, the tyrosine kinase receptor VEGFR-2 is primarily expressed in endothelial cells (ECs). These cells regulate various physiological responses, including differentiation, cell proliferation, migration, and survival, by binding to VEGF mitogens. Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) is a key regulator of this process, making it a prime target for therapeutic intervention. Several drugs targeting VEGFR-2 have been approved and are currently utilized to halt the pathological axis of VEGF-VEGFR. This review will focus on the recent developments in the molecular structure and function of VEGFR-2, the molecular mechanism of VEGFR-2 activation, and its downstream signaling pathway. It will also discuss therapies and experimental drugs approved to inhibit the function of VEGFR-2 and the resistance mechanism.</p></div>","PeriodicalId":8287,"journal":{"name":"Archives of Pharmacal Research","volume":"48 5","pages":"404 - 425"},"PeriodicalIF":6.9,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s12272-025-01545-1.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143963470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deficiency of β-arrestin2 ameliorates MASLD in mice by promoting the activation of TAK1/AMPK signaling 缺乏β-arrestin2可通过促进TAK1/AMPK信号的激活来改善小鼠的MASLD。
IF 6.9 3区 医学
Archives of Pharmacal Research Pub Date : 2025-05-08 DOI: 10.1007/s12272-025-01544-2
Ting-Ting Chen, Shan Shan, Ya-Ning Chen, Meng-Qi Li, Hui-Juan Zhang, Ling Li, Ping-Ping Gao, Nan Li, Yan Huang, Xiao-Lei Li, Wei Wei, Wu-Yi Sun
{"title":"Deficiency of β-arrestin2 ameliorates MASLD in mice by promoting the activation of TAK1/AMPK signaling","authors":"Ting-Ting Chen,&nbsp;Shan Shan,&nbsp;Ya-Ning Chen,&nbsp;Meng-Qi Li,&nbsp;Hui-Juan Zhang,&nbsp;Ling Li,&nbsp;Ping-Ping Gao,&nbsp;Nan Li,&nbsp;Yan Huang,&nbsp;Xiao-Lei Li,&nbsp;Wei Wei,&nbsp;Wu-Yi Sun","doi":"10.1007/s12272-025-01544-2","DOIUrl":"10.1007/s12272-025-01544-2","url":null,"abstract":"<div><p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a liver manifestation of metabolic syndrome characterized by excessive hepatic lipid accumulation and lipid metabolism disorders. It has become the most common chronic liver disease worldwide. β-arrestin2 is a multifunctional scaffold protein that is among the most important regulatory molecules, and it exerts key roles in regulating various cellular processes, such as immune response, cellular collagen production, and inflammation. In the current study, we aimed to explore the function of β-arrestin2 in the development and progression of MASLD. Firstly, we observed that the expression of β-arrestin2 was upregulated in liver samples from patients with MASLD. Then, the western diet (WD) combined with CCl<sub>4</sub> injection-induced MASLD was established in wild-type mice, and showed that liver β-arrestin2 expression was also gradually increased, and positively correlated with the degree of lipid metabolism disorder during MASLD progression. Ulteriorly, β-arrestin2 knockout (<i>Arrb2</i> KO) mice were utilized to induce the MASLD model and found that β-arrestin2 deficiency significantly ameliorated lipid accumulation and inflammatory response in the liver of MASLD mice. Furthermore, the in vitro depletion and overexpression experiments showed that increased β-arrestin2 aggravated lipid accumulation via inhibiting the activation of the TAK1/AMPK pathway, which may be mediated by competitively binding to TAB1 with TAK1. These findings suggest that β-arrestin2 is essential to regulate intrahepatic lipid metabolism. Here, we provide a novel insight in understanding of the expression and function of β-arrestin2 in MASLD, demonstrating that it may be a potential therapeutic target for MASLD treatment.</p></div>","PeriodicalId":8287,"journal":{"name":"Archives of Pharmacal Research","volume":"48 5","pages":"384 - 403"},"PeriodicalIF":6.9,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143952573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RSK2 and its binding partners: an emerging signaling node in cancers RSK2及其结合伙伴:癌症中新出现的信号节点
IF 6.9 3区 医学
Archives of Pharmacal Research Pub Date : 2025-05-05 DOI: 10.1007/s12272-025-01543-3
Hye Suk Lee, Sung-Jun Cho, Han Chang Kang, Joo Young Lee, Young Jik Kwon, Yong-Yeon Cho
{"title":"RSK2 and its binding partners: an emerging signaling node in cancers","authors":"Hye Suk Lee,&nbsp;Sung-Jun Cho,&nbsp;Han Chang Kang,&nbsp;Joo Young Lee,&nbsp;Young Jik Kwon,&nbsp;Yong-Yeon Cho","doi":"10.1007/s12272-025-01543-3","DOIUrl":"10.1007/s12272-025-01543-3","url":null,"abstract":"<div><p>The growth factor-mediated mitogen-activated protein kinase (MAPK) signaling pathways in cancer development have become increasingly important in the discovery of therapeutic agents for the treatment of cancer. RSK2 has been historically overlooked in studies regarding its involvement in physiology and signaling pathways related to human diseases, except for Coffin-Lowry syndrome, because it is located downstream of ERKs. For the last 25 years, the authors’ laboratory has made groundbreaking discoveries regarding the role of RSK2, especially by elucidating its binding partners, signaling network, and crosstalk. RSK2 is an important emerging target for developing anticancer drugs. Nevertheless, further studies on the detailed mechanism and signaling network are necessary to avoid the unexpected effects of RSK2 inhibitors. This paper describes a new paradigm of RSK2, where it works as a signaling node to modulate diverse cellular processes, including cell proliferation and transformation, cell cycle regulation, chromatin remodeling, and immune response and inflammation regulation.</p></div>","PeriodicalId":8287,"journal":{"name":"Archives of Pharmacal Research","volume":"48 5","pages":"365 - 383"},"PeriodicalIF":6.9,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143966867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanistic insights and emerging therapeutic strategies targeting endothelial dysfunction in cardiovascular diseases 针对心血管疾病中内皮功能障碍的机制见解和新兴治疗策略
IF 6.9 3区 医学
Archives of Pharmacal Research Pub Date : 2025-04-29 DOI: 10.1007/s12272-025-01542-4
Kyung-Sun Heo, Lan Phuong Phan, Nhi Thi Thao Le, Yujin Jin
{"title":"Mechanistic insights and emerging therapeutic strategies targeting endothelial dysfunction in cardiovascular diseases","authors":"Kyung-Sun Heo,&nbsp;Lan Phuong Phan,&nbsp;Nhi Thi Thao Le,&nbsp;Yujin Jin","doi":"10.1007/s12272-025-01542-4","DOIUrl":"10.1007/s12272-025-01542-4","url":null,"abstract":"<div><p>Endothelial dysfunction plays a pivotal role in the pathogenesis of various cardiovascular diseases (CVDs), including atherosclerosis, hypertension, heart failure, stroke, and peripheral artery disease. It disrupts vascular homeostasis, leading to reduced nitric oxide (NO) bioavailability, increased oxidative stress, and chronic inflammation, all of which collectively drive vascular damage, atherosclerotic plaque formation, and thrombosis. Additionally, shear stress-induced alterations in blood flow patterns, particularly disturbed flow (d-flow), aggravate endothelial dysfunction. Furthermore, the endothelial-to-mesenchymal transition (EndMT), a process in which endothelial cells acquire mesenchymal-like properties, contributes to vascular remodeling and accelerates CVD progression.</p><p>This review explores the significant role of epigenetic mechanisms, such as DNA methylation, histone modifications, and noncoding RNAs (ncRNAs), which serve as critical regulators of endothelial function in response to shear stress in endothelial dysfunction and the development of atherosclerosis. Furthermore, we discuss the pivotal role of endothelial dysfunction in cardiovascular and metabolic diseases, emphasizing the need for innovative therapeutic strategies beyond conventional treatments. In particular, we highlight the endothelial-protective mechanisms of emerging pharmacological agents, including proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1RAs), and sodium-glucose cotransporter 2 (SGLT2) inhibitors, along with supporting clinical evidence demonstrating their efficacy in improving endothelial function and reducing cardiovascular risk.</p></div>","PeriodicalId":8287,"journal":{"name":"Archives of Pharmacal Research","volume":"48 4","pages":"305 - 332"},"PeriodicalIF":6.9,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143913942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PET tracer development for imaging α-synucleinopathies 显像α-突触核蛋白病的PET示踪剂开发
IF 6.9 3区 医学
Archives of Pharmacal Research Pub Date : 2025-04-14 DOI: 10.1007/s12272-025-01538-0
Mohammad Maqusood Alam, Sun Hak Lee, Sobia Wasim, Sang-Yoon Lee
{"title":"PET tracer development for imaging α-synucleinopathies","authors":"Mohammad Maqusood Alam,&nbsp;Sun Hak Lee,&nbsp;Sobia Wasim,&nbsp;Sang-Yoon Lee","doi":"10.1007/s12272-025-01538-0","DOIUrl":"10.1007/s12272-025-01538-0","url":null,"abstract":"<div><p>Abnormal α-synuclein aggregation is a key neuropathological hallmark of α-synucleinopathies, such as Parkinson’s disease (PD), multiple system atrophy (MSA), and several other neurological disorders, and closely contributes to pathogenesis. The primary characteristics of α-synucleinopathies are selective targeted neurodegeneration and the accumulation of Lewy pathologies. Specifically, α-synuclein positron emission tomography (PET) radiotracers target the fibrillar forms of the protein, thus enhancing early diagnosis and the evaluation of treatment effectiveness for various α-synucleinopathies. Therefore, in vivo detection of α-synuclein aggregates using targeted radiolabeled probes would aid in drug development, early diagnosis, and ongoing disease monitoring. As such, no promising α-synuclein biomarkers suitable for clinical applications have been reported. PET is a valuable non-invasive technique for imaging drug distribution in tissues and receptor occupancy at target sites in living animals and humans. Advances in PET biomarkers have significantly enhanced our understanding of the mechanisms underlying PD. This review summarizes recent ongoing efforts in the development of selective PET tracers for α-synuclein and discusses future perspectives.</p></div>","PeriodicalId":8287,"journal":{"name":"Archives of Pharmacal Research","volume":"48 4","pages":"333 - 350"},"PeriodicalIF":6.9,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143913926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A review on bacteria-derived antioxidant metabolites: their production, purification, characterization, potential applications, and limitations 综述了细菌来源的抗氧化代谢物:它们的生产、纯化、表征、潜在的应用和局限性
IF 6.9 3区 医学
Archives of Pharmacal Research Pub Date : 2025-04-10 DOI: 10.1007/s12272-025-01541-5
Nazli Pinar Arslan, Fakhrul Azad, Tugba Orak, Aysenur Budak-Savas, Serkan Ortucu, Pranav Dawar, Mustafa Ozkan Baltaci, Hakan Ozkan, Nevzat Esim, Mesut Taskin
{"title":"A review on bacteria-derived antioxidant metabolites: their production, purification, characterization, potential applications, and limitations","authors":"Nazli Pinar Arslan,&nbsp;Fakhrul Azad,&nbsp;Tugba Orak,&nbsp;Aysenur Budak-Savas,&nbsp;Serkan Ortucu,&nbsp;Pranav Dawar,&nbsp;Mustafa Ozkan Baltaci,&nbsp;Hakan Ozkan,&nbsp;Nevzat Esim,&nbsp;Mesut Taskin","doi":"10.1007/s12272-025-01541-5","DOIUrl":"10.1007/s12272-025-01541-5","url":null,"abstract":"<div><p>Antioxidants are organic molecules that scavenge reactive oxygen species (ROS) and reactive nitrogen species (RNS), thereby maintaining cellular redox balance in living organisms. The human body synthesizes endogenous antioxidants, whereas humans obtain exogenous antioxidants from other organisms such as plants, animals, fungi, and bacteria. This review primarily focuses on the antioxidant potential of natural metabolites and extracts from five major bacterial phyla, including the well-studied <i>Actinobacteria</i> and <i>Cyanobacteria</i>, as well as less-studied <i>Bacteroides</i>, <i>Firmicutes</i>, and <i>Proteobacteria</i><i>.</i> The literature survey revealed that the metabolites and the extracts with antioxidant activity can be obtained from bacterial cells and their culture supernatants. The metabolites with antioxidant activity include pigments, phycobiliproteins, polysaccharides, mycosporins-like amino acids, peptides, phenolic compounds, and alkaloids. Both metabolites and extracts demonstrate in vitro antioxidant capacity through radical-scavenging, metal-reducing, and metal-chelating activity assays. In in vivo models, they can scavenge ROS and RNS directly and/or indirectly eliminate them by enhancing the activities of antioxidant enzymes, such as catalase, superoxide dismutase, and glutathione peroxidase. Due to their antioxidant activities, they may find applications in the cosmetic industry as anti-aging agents for the skin and in medicine as drugs or supplements for combating oxidative stress-related disorders, such as neurodegenerative diseases and diabetes. The literature survey also elucidated that some metabolites and extracts with antioxidant activity also exhibited strong antimicrobial properties. Therefore, we consider that they may have future applications in the treatment of infectious diseases, the preparation of pathogen-free healthy foods, and the extension of food shelf life.</p></div>","PeriodicalId":8287,"journal":{"name":"Archives of Pharmacal Research","volume":"48 4","pages":"253 - 292"},"PeriodicalIF":6.9,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s12272-025-01541-5.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143913892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The dynamic roles of macrophages extracellular traps (METs) in immune regulation 巨噬细胞胞外陷阱(METs)在免疫调节中的动态作用。
IF 6.9 3区 医学
Archives of Pharmacal Research Pub Date : 2025-04-05 DOI: 10.1007/s12272-025-01540-6
Yunjin Shin, Hanyoung Bae, Chaelin Lee, Inmoo Rhee
{"title":"The dynamic roles of macrophages extracellular traps (METs) in immune regulation","authors":"Yunjin Shin,&nbsp;Hanyoung Bae,&nbsp;Chaelin Lee,&nbsp;Inmoo Rhee","doi":"10.1007/s12272-025-01540-6","DOIUrl":"10.1007/s12272-025-01540-6","url":null,"abstract":"<div><p>Macrophages are crucial to innate immunity, eliminating pathogens and damaged tissues through phagocytosis and modulating immune responses. Recently, macrophage extracellular traps (METs) have been identified as chromatin-based structures composed of DNA and various immune-related proteins. While METs play a defensive role in trapping and neutralizing pathogens, they are also implicated in disease pathology, contributing to chronic inflammation, tissue damage, and immune dysregulation. The precise mechanisms regulating MET formation are still under investigation, but emerging evidence indicates the involvement of various regulatory factors. Dysregulated MET activity has been associated with various diseases, including autoimmune disorders, cancer, and neurological conditions. A deeper understanding of MET mechanisms and their pathological impact may offer novel therapeutic strategies. Given the limited number of reviews and articles on METs, this review provides valuable insights into MET formation, regulatory pathways, and their role in disease progression.</p></div>","PeriodicalId":8287,"journal":{"name":"Archives of Pharmacal Research","volume":"48 4","pages":"293 - 304"},"PeriodicalIF":6.9,"publicationDate":"2025-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143787527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The inhibition of endothelial DLL4-NOTCH1 signaling by 2'-hydroxyflavanone enhances anti-PD-1 therapy in melanoma 2'-hydroxyflavanone 对内皮 DLL4-NOTCH1 信号的抑制增强了黑色素瘤的抗 PD-1 治疗。
IF 6.9 3区 医学
Archives of Pharmacal Research Pub Date : 2025-04-02 DOI: 10.1007/s12272-025-01539-z
Jihye You, Seunghwan Ha, Doyoung Kim, Hyoung-Geun Kim, Se Ha Kim, Ji-Hak Jeong, Changmin Oh, Nam-In Baek, Jong Hwa Jung, Jeong Ah Kim, You Mie Lee
{"title":"The inhibition of endothelial DLL4-NOTCH1 signaling by 2'-hydroxyflavanone enhances anti-PD-1 therapy in melanoma","authors":"Jihye You,&nbsp;Seunghwan Ha,&nbsp;Doyoung Kim,&nbsp;Hyoung-Geun Kim,&nbsp;Se Ha Kim,&nbsp;Ji-Hak Jeong,&nbsp;Changmin Oh,&nbsp;Nam-In Baek,&nbsp;Jong Hwa Jung,&nbsp;Jeong Ah Kim,&nbsp;You Mie Lee","doi":"10.1007/s12272-025-01539-z","DOIUrl":"10.1007/s12272-025-01539-z","url":null,"abstract":"<div><p>Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapeutics; however limited patient responses necessitate combination strategies to improve therapeutic efficacy. Among potential combination partners, drugs targeting DLL4-NOTCH1 signaling pathway—a critical regulator of vascular function—show promise as angiogenesis modulators, but their clinical development have been hindered by safety concerns. To address this challenge, we adopted a novel approach by screening natural compounds with a long history of human consumption. Building upon our earlier findings, we identified three inhibitors of DLL4-NOTCH1 signaling: steppogenin, sanggenon F, and dehydrovomifoliol. Steppogenin inhibited both DLL4 and NOTCH1 activities, while sanggenon F and dehydrovomifoliol selectively suppressed DLL4 and NOTCH1 activity, respectively. We assessed their impact on key angiogenic processes, including endothelial cell migration, sprouting, and proliferation, and elucidated the relative contributions of selective DLL4 or NOTCH1 inhibition to the anti-angiogenic effect. By comparing structurally similar compounds, we identified the 2'-hydroxyflavanone moiety as a key element for DLL4 inhibition. Notably, combining steppogenin with an ICI demonstrated that a nature-derived angiogenesis inhibitor can boost the anti-cancer effect of ICI in a mouse melanoma allograft model. This comprehensive analysis of structure–activity relationships and in vivo therapeutic evaluation provides valuable insights into the development of novel anti-angiogenic compounds for combination therapy with ICIs in cancer treatment.</p></div>","PeriodicalId":8287,"journal":{"name":"Archives of Pharmacal Research","volume":"48 4","pages":"351 - 364"},"PeriodicalIF":6.9,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143762934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Covalent organic frameworks in cancer theranostics: advancing biomarker detection and tumor-targeted therapy 共价有机框架在癌症治疗中的应用:推进生物标志物检测和肿瘤靶向治疗。
IF 6.9 3区 医学
Archives of Pharmacal Research Pub Date : 2025-03-22 DOI: 10.1007/s12272-025-01536-2
Sonia Iranpour, Amir Abrishami, Amir Sh. Saljooghi
{"title":"Covalent organic frameworks in cancer theranostics: advancing biomarker detection and tumor-targeted therapy","authors":"Sonia Iranpour,&nbsp;Amir Abrishami,&nbsp;Amir Sh. Saljooghi","doi":"10.1007/s12272-025-01536-2","DOIUrl":"10.1007/s12272-025-01536-2","url":null,"abstract":"<div><p>In recent years, covalent organic frameworks (COFs) have garnered considerable attention in the field of onco-nanotechnology as a new type of nanoporous construct due to their promising physicochemical properties, ease of modification, and ability to be coupled with several moieties and therapeutic molecules. They can not only be used as biocompatible nanocarriers to deliver therapeutic payloads to the tumor zone selectively but can also be combined with a variety of therapeutic modalities to achieve the desired treatments. This review comprehensively presented recent achievements and progress in COF-based cancer diagnosis, detection, and cancer therapy to provide a better prospect for further research. Herein our primary emphasis lies on exploring the application of COFs as potential sensors for cancer-derived biomarkers that have received comparatively less attention in previous discussions. While the utilization of COFs in solid tumor therapy has faced significant challenges in scientific research and clinical applications, we reviewed the most promising features that underscore their potential in cancer theranostics.</p></div>","PeriodicalId":8287,"journal":{"name":"Archives of Pharmacal Research","volume":"48 3","pages":"183 - 211"},"PeriodicalIF":6.9,"publicationDate":"2025-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143676710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of binge drinking on alcoholic liver disease 酗酒对酒精性肝病的影响。
IF 6.9 3区 医学
Archives of Pharmacal Research Pub Date : 2025-03-04 DOI: 10.1007/s12272-025-01537-1
Jisoo Kang, Seol Hee Park, Mushira Khanam, Seo Bhin Park, Sumin Shin, Wonhyo Seo
{"title":"Impact of binge drinking on alcoholic liver disease","authors":"Jisoo Kang,&nbsp;Seol Hee Park,&nbsp;Mushira Khanam,&nbsp;Seo Bhin Park,&nbsp;Sumin Shin,&nbsp;Wonhyo Seo","doi":"10.1007/s12272-025-01537-1","DOIUrl":"10.1007/s12272-025-01537-1","url":null,"abstract":"<div><p>Numerous studies have examined the pathophysiological changes induced by chronic alcohol (ethanol) consumption and the underlying mechanisms, while much less attention has been devoted to understanding the health impacts of binge drinking. Binge drinking is defined as the excessive consumption of alcohol within a single drinking episode, and is the typical consumption pattern among young people in Western countries. While most young binge drinkers are not clinically alcohol dependent, binge drinking has emerged as a significant social and public health concern. The circulating alcohol consumed during binge episodes permeates cellular membranes throughout the body, exerting profound effects on multiple organs, and signaling pathways. Regular binge drinking eventually induces hepatic steatosis (fatty liver), initiates acute inflammation, and accelerates neutrophil infiltration, de novo lipogenesis, adipocyte death/lipolysis, and the production of nonoxidative alcohol metabolites, processes that synergize to damage liver tissue and impair liver function. Metabolic abnormalities such as diabetes and obesity can also exacerbate the progression of alcohol-related liver disease among binge drinkers. Several animal models have been developed to evaluate the pathophysiological changes resulting from binge drinking; however, the pathogenesis of binge drinking is not fully understood due to differences in alcohol metabolism between animal models and humans. Thus, given the high prevalence and severe health implications of binge drinking, there is an urgent need for comprehensive experimental and clinical investigations to unravel the associated pathophysiological changes. This review summarizes recent research findings on the impact of binge drinking, specifically focusing on its contributions to alcoholic liver injury.</p></div>","PeriodicalId":8287,"journal":{"name":"Archives of Pharmacal Research","volume":"48 3","pages":"212 - 223"},"PeriodicalIF":6.9,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143539840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信